Sevelamer Carbonate NDC 65862-931

NDC codes

FDA NDC Directory

Product NDC (as listed)65862-931Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65862-0931Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
65862-931-90	65862093190	90 POUCH in 1 CARTON (65862-931-90) / 1 POWDER, FOR SUSPENSION in 1 POUCH (65862-931-08)Marketed from Jun 13, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sevelamer Carbonate
Generic name (nonproprietary): sevelamer carbonate
Active ingredients: Sevelamer carbonate — 2400 mg/1
Dosage form: Powder, For suspension
Route: Oral
Labeler: Aurobindo Pharma Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207624
Marketing start: Jun 13, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Phosphate Chelating Activity (Mechanism)
Identifiers: Product ID 65862-931_e8c6db3c-3509-4033-8161-555236328bedSPL ID e8c6db3c-3509-4033-8161-555236328bedSPL set ID ea201bff-cdfb-4304-bdb1-d05c1dac2677RxCUI 861370, 861375UNII 9YCX42I8IU
Pharmacologic class: Phosphate Binder

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465862093190 followed by a unit qualifier and the quantity

Package 65862-0931-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 8, 2023.

Indications (excerpt from the label)

Sevelamer carbonate for oral suspension is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis. Sevelamer carbonate for oral suspension is a phosphate binder indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on dialysis. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 207624

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207624
Product	Strength	Form · route	Labeler	Product NDC
Sevelamer Carbonate	Sevelamer carbonate 800 mg/1	Powder, For suspensionOral	Aurobindo Pharma Limited	65862-930